For: | Tong DY, Wang XH, Xu CF, Yang YZ, Xiong SD. Hepatitis B virus infection and coronary atherosclerosis: Results from a population with relatively high prevalence of hepatitis B virus. World J Gastroenterol 2005; 11(9): 1292-1296 [PMID: 15761966 DOI: 10.3748/wjg.v11.i9.1292] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i9/1292.htm |
Number | Citing Articles |
1 |
M. U. Farooq, A. Majid, M. J. Reeves, G. L. Birbeck. The Epidemiology of Stroke in Pakistan: Past, Present, and Future. International Journal of Stroke 2009; 4(5): 381 doi: 10.1111/j.1747-4949.2009.00327.x
|
2 |
Chia‐Chi Wang, Tai‐Chung Tseng, Jia‐Horng Kao. Hepatitis B virus infection and metabolic syndrome: Fact or fiction?. Journal of Gastroenterology and Hepatology 2015; 30(1): 14 doi: 10.1111/jgh.12700
|
3 |
Yaqin Wang, Jianping Xiong, Meng Niu, Weiyu Xu, Ke Xu, Hongshan Zhong. Hepatitis B virus and the risk of coronary heart disease: A comprehensive systematic review and meta-analyses of observational studies. International Journal of Cardiology 2018; 265: 204 doi: 10.1016/j.ijcard.2018.04.059
|
4 |
Yong Fan, Jiajun Ying, Hongchuang Ma, Hanbin Cui. Microbiota‐related metabolites fueling the understanding of ischemic heart disease. iMeta 2023; 2(2) doi: 10.1002/imt2.94
|
5 |
Pei-Lun Kuo, Kun-Chang Lin, Pei-Ling Tang, Chin-Chang Cheng, Wei-Chun Huang, Cheng-Hung Chiang, Hsiao-Chin Lin, Tzu-Jung Chuang, Shue-Ren Wann, Guang-Yuan Mar, Jin-Shiung Cheng, Chun-Peng Liu. Contribution of Hepatitis B to Long-Term Outcome Among Patients With Acute Myocardial Infarction. Medicine 2016; 95(5): e2678 doi: 10.1097/MD.0000000000002678
|
6 |
Chao‐Tung Chen, Wei‐Cheng Huang, Jing‐Houng Wang, Chuan‐Mo Lee, Chao‐Hung Hung, Lin‐San Tsai, Shu‐Chuan Chen, Sheng‐Che Lin, Sheng‐Nan Lu, Kwong‐Ming Kee. Endemic hepatitis B and C virus areas are associated with lower prevalence of hyperlipidemia: Ecological and cross‐sectional studies. Advances in Digestive Medicine 2017; 4(2): 54 doi: 10.1002/aid2.12054
|
7 |
Samarth S. Patel, Eiman Nabi, Luis Guzman, Antonio Abbate, Chandra Bhati, Richard T. Stravitz, Trevor Reichman, Scott C. Matherly, Carolyn Driscoll, Hannah Lee, Velimir A. Luketic, Richard K. Sterling, Arun J. Sanyal, Vaishali Patel, Marlon Levy, Mohammad Shadab Siddiqui. Coronary artery disease in decompensated patients undergoing liver transplantation evaluation. Liver Transplantation 2018; 24(3): 333 doi: 10.1002/lt.25012
|
8 |
Dao-Fu Dai, Jou-Wei Lin, Jia-Horng Kao, Chih-Neng Hsu, Fu-Tien Chiang, Jiunn-Lee Lin, Yi-Hua Chou, Kwan-Lih Hsu, Chuen-Den Tseng, Yung-Zu Tseng, Juey-Jen Hwang. The Effects of Metabolic Syndrome Versus Infectious Burden on Inflammation, Severity of Coronary Atherosclerosis, and Major Adverse Cardiovascular Events. The Journal of Clinical Endocrinology & Metabolism 2007; 92(7): 2532 doi: 10.1210/jc.2006-2428
|
9 |
Ho Soo Chun, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim. Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B. Digestive Diseases and Sciences 2022; 67(7): 3412 doi: 10.1007/s10620-021-07157-1
|
10 |
Joohon Sung, Yun-Mi Song, Yoon-Ho Choi, Shah Ebrahim, George Davey Smith. Hepatitis B Virus Seropositivity and the Risk of Stroke and Myocardial Infarction. Stroke 2007; 38(5): 1436 doi: 10.1161/STROKEAHA.106.466268
|
11 |
Ivan Ranković, Vladimir Milivojević, Aleksandra Pavlović Marković, Mihailo Bezmarević. Interplay between chronic hepatitis B and atherosclerosis: Innovative perspectives and theories. World Journal of Gastroenterology 2022; 28(4): 497-499 doi: 10.3748/wjg.v28.i4.497
|
12 |
Mar Masiá, Félix Gutiérrez. Factores de riesgo cardiovascular dependientes de la infección por VIH. Enfermedades Infecciosas y Microbiología Clínica 2009; 27: 17 doi: 10.1016/S0213-005X(09)73441-X
|
13 |
HBV or HCV Coinfections and Risk of Myocardial Infarction in HIV-Infected Individuals: The D:A:D Cohort Study. Antiviral Therapy 2010; 15(8): 1077 doi: 10.3851/IMP1681
|
14 |
Reza Ghotaslou, Nasser Aslanabadi, Morteza Ghojazadeh. Hepatitis B Virus Infection and the Risk of Coronary Atherosclerosis. Annals of the Academy of Medicine, Singapore 2008; 37(11): 913 doi: 10.47102/annals-acadmedsg.V37N11p913
|
15 |
Tae-Heum Chung, Moon-Chan Kim, Chang-Sup Kim. Association between Hepatitis B Surface Antigen Seropositivity and Metabolic Syndrome. Korean Journal of Family Medicine 2014; 35(2): 81 doi: 10.4082/kjfm.2014.35.2.81
|
16 |
Chih-Hao Wang, Chien-Jen Chen, Mei-Hsuan Lee, Hwai-I Yang, Chuhsing Kate Hsiao. Chronic hepatitis B infection and risk of atherosclerosis-related mortality: A 17-year follow-up study based on 22,472 residents in Taiwan. Atherosclerosis 2010; 211(2): 624 doi: 10.1016/j.atherosclerosis.2010.03.008
|
17 |
Frederik Faergemann Lau, Signe Bollerup, Frederik Engsig, Henrik Krarup, Lone Hagens Mygind, Jesper Bach Hansen, Lone Galmstrup Madsen, Peter Thielsen, Ulla Balslev, Lars Nørregaard Nielsen, Toke S Barfod, Mette Rye Clausen, Lise Hobolth, Alex Lund Laursen, Britta Tarp, Birgit T Roege, Jan Gerstoft, Peer Brehm Christensen, Nina Weis. Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study. Clinical Epidemiology 2022; : 879 doi: 10.2147/CLEP.S361910
|
18 |
Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary Pharmacology & Therapeutics 2020; 51(2): 216 doi: 10.1111/apt.15575
|
19 |
Ali Raza Kazmi, Andleeb Hanif, Muhammad Ismail, Javaria Qazi. Hyperhomoysteinemia as a risk factor for coronary heart diseases in chronic hepatitis C patients. World Journal of Cardiovascular Diseases 2013; 3(08): 499 doi: 10.4236/wjcd.2013.38079
|
20 |
T. T. Lao, D. S. Sahota, Y. K. Y. Cheng, L. W. Law, T. Y. Leung. Maternal hepatitis B surface antigen status and incidence of pre‐eclampsia. Journal of Viral Hepatitis 2013; 20(5): 343 doi: 10.1111/jvh.12037
|
21 |
Ashish Kumar, Mariam Shariff, Rajkumar Doshi. Association Between Past Hepatitis B Infection and Ischemic Heart Disease: An Analysis From the 2007-2016 NHANES Data. The American Journal of the Medical Sciences 2020; 360(4): 372 doi: 10.1016/j.amjms.2020.05.034
|
22 |
Shigeo Maruyama, Masahiko Koda, Yoshikazu Murawaki. Myocardial perfusion defects in patients with chronic hepatitis B infection. Journal of Gastroenterology and Hepatology 2014; 29(4): 794 doi: 10.1111/jgh.12453
|
23 |
Chin-Sung Kuo, Yung-Tai Chen, Chien-Yi Hsu, Chun-Chin Chang, Ruey-Hsing Chou, Szu-Yuan Li, Shu-Chen Kuo, Po-Hsun Huang, Jaw-Wen Chen, Shing-Jong Lin. The impact of chronic hepatitis B infection on major adverse cardiovascular events and all-cause mortality in patients with diabetes: a nationwide population-based study from Taiwan. BMJ Open 2017; 7(8): e016179 doi: 10.1136/bmjopen-2017-016179
|
24 |
Atefe Ghamar Talepoor, Mehrnoosh Doroudchi. Immunosenescence in atherosclerosis: A role for chronic viral infections. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.945016
|
25 |
Bin Cai, James S. Panek, Salomon Amar. Convergent Synthesis of Novel Muramyl Dipeptide Analogues: Inhibition of Porphyromonas gingivalis-Induced Pro-inflammatory Effects by High Doses of Muramyl Dipeptide. Journal of Medicinal Chemistry 2016; 59(14): 6878 doi: 10.1021/acs.jmedchem.6b00681
|
26 |
Zun-Ping Ke, Miao Gong, Gang Zhao, Yue Geng, Kuan Cheng, Neelam Yadav. Association between HBV Infection and the Prevalence of Coronary Artery Disease in the US Population. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/5062798
|
27 |
Anton Kutikhin, Elena Brusina, Arseniy E. Yuzhalin. Viruses and Atherosclerosis. SpringerBriefs in Immunology 2013; 4: 49 doi: 10.1007/978-1-4614-8863-7_5
|
28 |
Peter Jarcuska, Sylvia Drazilova, Jan Fedacko, Daniel Pella, Martin Janicko. Association between hepatitis B and metabolic syndrome: Current state of the art. World Journal of Gastroenterology 2016; 22(1): 155-164 doi: 10.3748/wjg.v22.i1.155
|
29 |
Nima Hemmat, Amin Ebadi, Reza Badalzadeh, Mohammad Yousef Memar, Hossein Bannazadeh Baghi. Viral infection and atherosclerosis. European Journal of Clinical Microbiology & Infectious Diseases 2018; 37(12): 2225 doi: 10.1007/s10096-018-3370-z
|
30 |
Giovanni Targher, Lorenzo Bertolini, Roberto Padovani, Stefano Rodella, Guido Arcaro, Christopher Day. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. Journal of Hepatology 2007; 46(6): 1126 doi: 10.1016/j.jhep.2007.01.021
|
31 |
Ş. Yilmaz, K. Bayan, Y. TüZüN, M. Dursun, A. Kaplan, Ş. Özmen, F. Canoruç, Z. Akkuş. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis. International Journal of Clinical Practice 2007; 61(3): 438 doi: 10.1111/j.1742-1241.2006.00912.x
|
32 |
Michael Rosenfeld, Lee Ann Campbell. Pathogens and atherosclerosis: Update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thrombosis and Haemostasis 2011; 106(11): 858 doi: 10.1160/TH11-06-0392
|
33 |
Tugrul Purnak, Cumali Efe, Yavuz Beyazit, Ersan Ozaslan, Ramazan Astan, Aysel Milanlıoglu, Zeynep Ozbalkan, Manfredi Rizzo. Recent Insights into the Relationship between Inflammatory Liver Diseases and Atherosclerosis. Journal of Investigative Medicine 2011; 59(6): 904 doi: 10.2310/JIM.0b013e318217f3a0
|
34 |
Meng-Chuan Lu, Ying-Hsuen Wu, Chi-Hsiang Chung, Hsuan-Hwai Lin, Tsai-Yuan Hsieh, Peng-Jen Chen, Wu-Chien Chien, Hsuan-Wei Chen. Association of Hepatitis B and C Virus with the Risk of Coronary Artery Disease and Cerebrovascular Disease in Patients with Hepatocellular Carcinoma. Journal of Clinical Medicine 2023; 12(7): 2602 doi: 10.3390/jcm12072602
|